ReviewToxicology2025
Importance of post-translational protein modifications in PFAS toxicity.
Review in Toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic compounds known for their high chemical stability, resistance to degradation. This class includes thousands of different compounds widely used in various products like non-stick cookware, water-repellent fabrics, food packaging, firefighting foam, and many personal care products. While these properties contribute to their industrial utility, they also pose significant environmental and health concerns due in part to long environmental and biological half-lives. PFAS contamination has been widely reported in water sources and soil, along with reports of bioaccumulation in the blood and tissues of living organisms. These chemicals have been linked to a range of health effects, including potential risks to cancer, neurotoxicity, and developmental disorders. Given their broad involvement in disease pathology, it is critical to investigate the underlying molecular mechanisms of PFAS toxicity. This review evaluates current research on the impact of various PFAS on different proteins, their post-translational modifications (PTMs), and the effects on cellular signalling pathways. It also reviews proteomic studies conducted over the years that aim to elucidate these protein-level changes, while highlighting existing gaps in the field. Despite growing attention to PFAS toxicity, significant advances are required in elucidating the primary mechanisms of toxic action. Studying PFAS effects from a proteome perspective could be very promising. In particular, the lack of organ-specific proteomic data, including studies on distinct brain regions and PTM-specific profiling, represents a critical area for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.